好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

MEF2 as an Anti-Apoptotic, Neurogenic Transcription Factor in Murine ES Cells: Beneficial Effect of Transplantation after Middle Cerebral Artery Stroke in Mice
Cerebrovascular Disease and Interventional Neurology
(-)
001
Authors/Disclosures
Stuart A. Lipton, MD, PhD, FAAN (The Scripps Research Institute) Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Deerfield Management. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Panorama Research, Inc.. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Circumvent Therapeutics, Inc.. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Harvard Medical School/Boston Children's Hostpial. Dr. Lipton has stock in EuMentis Therapeutics, Inc.. The institution of Dr. Lipton has received research support from NIH. The institution of Dr. Lipton has received research support from CIRM California Institute for Regenerative Medicine. The institution of Dr. Lipton has received research support from TRDRP California Tobacco Related Research/UCOP. The institution of Dr. Lipton has received research support from Circumvent Pharmaceuticals. Dr. Lipton has received intellectual property interests from a discovery or technology relating to health care. Dr. Lipton has received intellectual property interests from a discovery or technology relating to health care. Dr. Lipton has received intellectual property interests from a discovery or technology relating to health care. Dr. Lipton has received intellectual property interests from a discovery or technology relating to health care. Dr. Lipton has a non-compensated relationship as a Associate Editor with Neuron (Cell Press) that is relevant to AAN interests or activities.
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Gary Tong, MD, PhD No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file